Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Infection
• Pertussis
• Pneumococcal Disease
• Poliomyelitis
• Tetanus
• Viral Hepatitis

Drugs mentioned

• Infanrix Hexa (DTPa-HBV-IPV/Hib)
• Pediacel (Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae type b, Hepatitis B vaccine (DTaP-IPV-Hib-HepB))
• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Infant, Healthy | Phase 3 | Status: COMPLETED